Professor of Biomedical Engineering
Embryonic and adult stem cell therapies for heart and muscle disease; cardiac and skeletal muscle tissue engineering; cardiac electrophysiology and arrhythmias; genetic modifications of stem and somatic cells; micropatterning of proteins and hydrogels.
I will be performing rodent surgeries to support cardiac and skeletal muscle studies.
I am working on human engineered skeletal and cardiac muscle for organ-on-chip studies.
I am the lab manager for the Bursac Lab, and I also assist lab members with molecular biology and cell culture.
I work on developing more physiologically relevant tissue engineered skeletal muscle to study both healthy and diseased muscle physiology in human and rat cells.
I study the mechanisms of ion channel trafficking in reponse to biomechanical cues.
I work on designing and engineering electrically active primary human cells with customized electrophysiological phenotypes for cardiac repair.
I am interested in the fidelity of the electrical system and the role of fibroblasts in cardiac regeneration.
My current project is focused on generating functional skeletal muscle bundles with cells derived from human pluripotent stem cells for drug development, disease modeling and implantation therapies.
I am interested in developing organ-on-chip platforms containing engineered cardiac and skeletal muscle microtissues to enable high throughput pharmacological and genome editing screening.
I am studying how the presence of immune cells affects the development and function of engineered skeletal muscle tissue.
I am working on cardiomyocyte proliferation in the context of regeneration.
I work on human cardiac tissue engineering from pluripotent stem cells, and gene editing.
I am currently interested in studying the role of polyploidy in the context of proliferation and maturation of human iPSC-derived cardiomyocytes.
I am exploring methods to improve the regenerative capacity of engineered tissues derived from human skeletal muscle cells.
I am studying the proliferation of cardiomyocytes.
I am currently working on the improvement of the structure and function of primary human and induced pluripotent stem cell engineered skeletal muscle tissues, which will be used for improved disease modeling of Duchenne muscular dystrophy and dysferlinopathy.
I am studying the treatment of Pompe’s disease in engineered tissues derived from human skeletal muscle cells.